|4Nov 1, 4:41 PM ET

Char Daniel 4

4 · Evelo Biosciences, Inc. · Filed Nov 1, 2018

Insider Transaction Report

Form 4
Period: 2018-10-31
Char Daniel
General Counsel
Transactions
  • Award

    Stock Option

    2018-10-31+100,000100,000 total
    Exercise: $9.11Exp: 2028-10-30Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the total grant on October 29, 2019 and vests in equal quarterly installments over a three year period thereafter

Documents

1 file
  • 4
    wf-form4_154110484713732.xmlPrimary

    FORM 4